Cytomegalovirus: Another Source of Antibody-mediated Graft Injury?

Affiliations

Comment

Charles H Cook. Transplantation. 2021.

. 2021 Aug 1;105(8):1653-1654.

doi: 10.1097/TP.0000000000003549.

¹ Department of Surgery, Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, MA.

No abstract available

Conflict of interest statement

The authors declare no funding or conflicts of interest.

Murine Cytomegalovirus-induced Complement-fixing Antibodies Deposit in Murine Renal Allografts During Acute Rejection.
Saunders U, Li M, Boddeda SR, Maher S, Ghere J, Kaptsan I, Dhital R, Velazquez V, Guo L, Chen B, Zeng Q, Schoeb TR, Cianciolo R, Shimamura M. Saunders U, et al. Transplantation. 2021 Aug 1;105(8):1718-1729. doi: 10.1097/TP.0000000000003548. Transplantation. 2021. PMID: 33214535 Free PMC article.

1. Schinstock CA, Mannon RB, Budde K, et al. Recommended treatment for antibody-mediated rejection after kidney transplantation: the 2019 expert consensus from the Transplantion Society Working Group. Transplantation. 2020;104:911–922.
1. Kotton CN, Kumar D, Caliendo AM, et al.; The Transplantation Society International CMV Consensus Group. The Third International Consensus guidelines on the management of cytomegalovirus in solid-organ transplantation. Transplantation. 2018;102:900–931.
1. Shimamura M, Saunders U, Rha B, et al. Ganciclovir transiently attenuates murine cytomegalovirus-associated renal allograft inflammation. Transplantation. 2011;92:759–766.
1. Saunders U. Murine cytomegalovirus-induced complement-fixing antibodies deposit in murine renal allografts during acute rejection. Transplantation. 2021;105:1718–1729.
1. Hummel M, Zhang Z, Yan S, et al. Allogeneic transplantation induces expression of cytomegalovirus immediate-early genes in vivo: a model for reactivation from latency. J Virol. 2001;75:4814–4822.